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TECHNIQUES
Ultrasound-Guided In Utero Injections Allow
Studies of the Development and Function of
the Eye
Claudio Punzo and Constance L. Cepko*
Ultrasound-guided in utero injections into the brain of murine embryos has been shown to facilitate gene
delivery. We investigated whether these methods would allow gene transfer into ocular structures. Gene
transfer using retroviral vectors or electroporation was found to be quite effective. We determined the
window of time, as well as compared several strains of mice, that yield a high degree of survival and
successful gene transfer. Several retroviral constructs were tested for expression and coexpresssion of two
genes in retinal cell types. In addition, a retroviral vector was engineered to give cone photoreceptor-
enriched expression, and a retroviral vector was demonstrated to provide RNAi-mediated loss-of-function.
These methods enable access to early ocular structures and provide a more rapid method of assessment of
gene and promoter function than possible using genetically engineered mice. Developmental Dynamics 237:
1034–1042, 2008. © 2008 Wiley-Liss, Inc.
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INTRODUCTION
The retina is a well-characterized tissue
of the central nervous system (CNS)
that has served as a model of CNS de-
velopment, circuitry, and degeneration
(Rodieck, 1998). It has a simple layered
structure, surrounded by several sup-
port tissues, such as the retinal pig-
mented epithelium (RPE) and sclera.
Much of mammalian ocular develop-
ment occurs in utero, making early ex-
perimental perturbations difﬁcult. Tra-
ditional genetic methods partially
overcome the lack of access, and the
recent applications using recombinases
such as Cre or Flp (Branda and Dy-
mecki, 2004), allow more precise gain-
and loss-of-function experiments. How-
ever, even this more recent approach is
often limited due to lethality or the lack
of appropriate Cre-driver lines that
function in the desired spatiotemporal
manner. Additionally, most Cre-driver
lines affect large populations of cells,
complicating the dissection of cell-au-
tonomous gene function. In Drosophila,
many questions regarding eye develop-
ment have been answered using elegant
clonal loss-of-function strategies that
rely upon mitotic recombination (Xu
and Rubin, 1993). Although these meth-
ods have been established for mice, they
involve time consuming and costly pro-
cedures that require embryonic stem
cells (Liu et al., 2002) and the genera-
tion of new mouse lines (Wang et al.,
2007).
Previous investigators had used ul-
trasound-guided injections to success-
fully target brain structures (Liu et
al., 1998; Gaiano et al., 1999). To over-
come the obstacles presented above,
we investigated whether methods us-
ing ultrasound-guided in utero manip-
ulations were also applicable to ocular
structures. Despite their much
smaller size, we found that gene
transfer into ocular structures was
successful. We tested several aspects
of the procedure to allow for high efﬁ-
ciency, including timing of injections,
mouse strains, and gene transfer by
means of electroporation and retrovi-
ral vectors.
RESULTS
Injection Method
Ultrasound-guided in utero injections
were performed as early as embryonic
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© 2008 Wiley-Liss, Inc.day (E) 9.5, to E10.5, and then again
between E12.5 and birth. At E9.5,
which is before the birth of any retinal
cell type, injections were into the lu-
men of the diencephalon of the devel-
oping embryo (Fig. 1A,B). At this time,
the lumen of the diencephalon is con-
tinuous with that of the optic vesicle,
which allows targeting of future reti-
nal and RPE cells. Once the optic cup
forms at approximately E10.5, the lu-
men constricts as the optic stalk
forms. Therefore, injections after
E10.5 need to be performed directly
into the subretinal space (Fig. 1C,D),
which is not possible until after E12.5,
as the subretinal space is too small to
target effectively earlier (Table 1).
Surgeries were performed with
isoﬂuorene anesthesia with survival
rates 96% for the mother when the
surgeries lasted 90 min. Average an-
esthesia time was 45 min. Survival
rates of embryos injected at E9.5–
E10.5 was 90%, and targeting efﬁ-
ciency of the eye was 80%. At and
after E12.5, survival rates dropped to
80% and targeting efﬁciency to
70% (Table 1). The decrease in sur-
vival at later stages was mainly due to
spontaneous abortions of the entire
litter. Proper positioning of larger size
embryos back into the body cavity of
the mother was crucial for prevention
of spontaneous abortions. The de-
crease in target efﬁciency was mainly
due to a reduced targeting area. Three
to four embryos were injected per
horn, selecting those that were in
ideal positions, to minimize manipula-
tion of the embryos. Injections at
E9.5–E10.5 usually resulted in both
eyes being targeted, because both op-
tic vesicles were open toward the di-
encephalon. Injections at later stages
were performed in only one of the two
eyes to reduce the degree of the ma-
nipulation. After the surgery, develop-
ment proceeded with a normal partu-
rition, whereupon pups were suckled
and raised by the mother. Strain dif-
ferences were observed in survival
rates of the pregnant mother for the
three stains tested, such that CD1 
FVB/N  C57Bl6.
Gene Transfer Methods
Two methods of gene transfer were
tested: retroviral infection and elec-
troporation. These methods have
some similarities, as well as some dif-
ferences, which are relevant for differ-
ent applications. One similarity is the
target cell that takes up the DNA. Vi-
ral infection with Type C retroviral
vectors as well as electroporation tar-
get mitotic progenitor cells. Electropo-
rated plasmid DNA either accesses
primarily mitotic cells, as they line the
lumen where the DNA is delivered, or
there is some selectivity in the type of
cells that can successfully translocate
the DNA to the nucleus, and/or ex-
press detectable levels of reporter
genes (Matsuda and Cepko, 2004).
Whereas type C retroviruses can inte-
grate only in mitotic cells (Miller et
al., 1990), lentiviral vectors can inte-
grate into postmitotic and mitotic cells
(Naldini et al., 1996). However, the
route of injection into a lumen might
only deliver the viral vector to the
area adjacent to mitotic cells, so even
the lentiviral infections tend to target
mitotic cells. Electroporated DNA or
viral DNA is then inherited by prog-
eny cells. The aspects that are quite
different are the stability of expres-
sion and the number of cells targeted,
as described further below.
Gene transfer by viral vectors.
Retroviruses enable indeﬁnite expres-
sion, by virtue of their integration into
the host genome. Moreover, by con-
trolling the viral titer, one can infect a
small number of cells, enabling clonal
analysis for lineage studies or distinc-
tions between autonomous and non-
autonomous effects. At E9.5–E10.5, a
minimal titer of 10
6 colony forming
units/ml (CFU/ml) was required for
successful infection, although this
only yielded a few clones per eye in
successfully infected animals, with a
targeting efﬁciency (percentage of an-
Fig. 1. Ultrasound-guided injections. A: Schematic representation of developing optic vesicles
(OV) at embryonic day (E) 9.5, with the orange arrow indicating the injection needle and blue dots
the injected viruses. B: Ultrasound image of embryo at E9.5 showing the injection needle (yellow
lines) and developing optic vesicles (arrow) and diencephalon. C: Schematic representation of
developing eye showing retina, retinal pigmented epithelium (RPE), and the subretinal space. The
orange arrow indicates the injection needle and blue dots the injected viruses. D: Ultrasound image
of developing eye at E13.5 showing injection needle (yellow lines), retina, retinal pigmented
epithelium, and subretinal space.
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80%. The targeting efﬁciency of ap-
proximately 80% was achieved with a
titer of 10
7 CFU/ml. If the number of
clones desired is small, so that clonal
analysis can be conducted, 5  10
6
CFU/ml is an ideal titer as most in-
fected animals will have a few clones
per eye. When infecting at E9.5–
E10.5, the clones are large; therefore,
one needs clones that are well sepa-
rated to avoid confusion in assign-
ment of clonal boundaries. With titers
of 10
8 CFU/ml, 20–30% of the sur-
face area of the retina had clones (see
Fig. 3G–I). For injections into the sub-
retinal space at E12.5 and later, a
minimum of 5  10
5 CFU/ml is recom-
mended. Higher concentrations work
and increase the number of clones.
The clone sizes varied relative to the
time of infection, such that earlier in-
fections resulted in larger clones, and
later infections resulted in relatively
smaller clones (Fig. 2; Turner et al.,
1990). As our previous work showed
that infections into E13–E14 pro-
duced clone sizes that varied tremen-
dously, from 1 to 234 cells with a large
standard deviation among 300
clones, it is difﬁcult to give a quanti-
tative description of the differences in
clone sizes in the current study as we
did not perform quantitative clonal
analysis on a large enough number of
clones to give statistically signiﬁcant
results. In addition to the trend in
clone size reduction relative to time of
infection, it was also apparent that,
due to the sequential birth of retinal
cell types, later injections resulted in
gene transfer into a reduced number
of cell types per clone, as seen previ-
ously and as predicted by birthdating
studies (Young, 1985; Turner and
Cepko, 1987; Turner et al., 1990).
Four different viral vectors were
tested for expression in retinal cell
types. Some promoters, including vi-
ral LTR promoters, can be silenced in
certain cell types, and silencing can
vary depending upon time of introduc-
tion into a tissue (Jaenisch, 1980; Ga-
iano et al., 1999). The four vectors
were FUGW (Lois et al., 2002), LIA
(Bao and Cepko, 1997), BAG (Price
and Thurlow, 1988), and pQCXIX
(Clontech). FUGW is a lentiviral vec-
tor with inactive LTR promoters. It
expresses cytoplasmic GFP from an
internal human ubiquitin C promoter.
LIA and BAG are derived from the
type C retrovirus Moloney murine leu-
kemia virus (MMLV) and express hu-
man placental alkaline phosphatase
and -galactosidase, respectively,
from slightly different MMLV LTRs.
The vector pQCXIX is similarly de-
rived from MMLV, but has inactive
LTRs, and it expresses nuclear green
ﬂuorescent protein (GFP; pQC-
H2BGFP-IX) from an internal CMV
promoter (see the Experimental Pro-
cedures section). It, like LIA, has an
internal ribosomal entry site (IRES)
element allowing for expression of two
genes from a bicistronic mRNA.
FUGW-infected retinas were difﬁ-
cult to identify due to low expression
levels of GFP. While expression was
seen in all expected cell types, inde-
pendent of the injected stage, levels
were low and only after antibody
staining with an -GFP antibody were
the cell types detected. LIA (Fig.
2A–C) did not yield the expected cel-
lular distribution within large clones
after infection at E9.5–E10.5, but did
give the expected results from infec-
tions at or after E12.5. Many clones
from injections at E9.5–E10.5 lacked
inner nuclear layer cells, although
many photoreceptors were labeled
(Fig. 2B), suggesting inactivation of
the LTR in some cell types. BAG (Fig.
2D–I) and pQCXIX gave the expected
result of large, complex clones with
labeling of many cell types in each
clone, after infection at all embryonic
ages tested, with the exception that
bipolar and possibly ganglion cells
were weakly labeled by pQCXIX (Fig.
TABLE 1. Comparison of Survival and Gene Transfer Efﬁciency Following Viral Infection and Electroporation
a
Injection stage E9.5–E10.5
* E9.5–E10.5
† E9.5–E10.5
§ E12.5
Gene transfer method Viral infection Viral infection Viral infection Viral infection or
electroporation
Location of injection Diencephalon Diencephalon Diencephalon Subretinal space
Survival rates of mothers 80%
12/15
100%
50/50
96%
62/65
93%
14/15
Survival rates of embryos 67%
103/153
97%
495/510
90%
598/663
80%
130/162
Target efﬁciency total 47%
31/65
88%
245/278
80%
276/343
71%
59/83
Target efﬁciency for viral titer 10
6 43%
15/35
71%
12/17
52%
27/52
71%
22/31
Target efﬁciency for viral titer 510
6 53%
16/30
75%
18/24
63%
34/54
71%
17/24
Target efﬁciency for viral titer 10
7 84%
103/122
84%
103/122
n.d.
Target efﬁciency for viral titer 10
8 97%
112/115
97%
112/115
n.d.
aSurvival rates of embryos were dependent primarily upon developmental stage and experience with the surgical procedure. They
did not depend on litter size, viral vector, or gene transfer method once electroporation conditions were optimized for particular
strain of mice. A detailed analysis for CD1 at E9.5-10.5 is as follows: *, values for ﬁrst 15 surgeries, †, values of remaining surgeries,
§, summary of column*&† ;survival rates of embryos  number of animals born / number of animals expected to be born; target
efﬁciency  number of positive animals / number of infected or electroporated animals. E, embryonic day; n.d., not determined.
1036 PUNZO AND CEPKO3A–C). Animals infected with
pQCXIX were easily identiﬁed with-
out dissection as the ﬂuorescent signal
from retinal clones could be visualized
through the lens of the eye (Fig. 3D).
After enucleation, examination of the
eye revealed nuclear GFP not only in
retinal cells, but also in the surround-
ing RPE and scleral tissue (Fig. 3E),
which was conﬁrmed by analysis of
sections (data not shown). Promoter
activity was followed up to 10 weeks
postnatal with no noticeable decrease
(Fig. 3F).
To determine whether the biscis-
tronic mRNA of pQCXIX was able to
direct signiﬁcant levels of coexpres-
sion, nuclear GFP and membrane-
Cherry (Shaner et al., 2004) were
cloned into the vector, with GFP 5 of
the IRES and cherry 3 of the IRES
(see the Experimental Procedures sec-
tion). Both genes were easily visual-
ized in the same cells, after infection
at E9.5 (Fig. 4A–C). This ﬁnding sug-
gests that coexpression of a gene of
interest to investigate gene function,
with a ﬂuorescent reporter gene,
should be successful. We further
tested whether pQCXIX could be en-
gineered to give cell type speciﬁcity
and whether it could support RNAi-
mediated loss-of-function. Viral vec-
tors can be engineered to direct ex-
pression to a speciﬁc cell type by
insertion of cell type-speciﬁc promot-
ers into vectors with inactive LTRs,
such as pQCXIX. To examine whether
this could be achieved after embryonic
infection, the CMV promoter of the
pQCXIX vector was replaced with the
cone arrestin promoter (Zhu et al.,
2002; see the Experimental Proce-
dures section). Strong expression in
cones was seen after infection at E9.5–
E10.5 (Fig. 4D–H). However, there
was some weak to strong labeling of
inner nuclear layer cells in some
clones, as well as some rod labeling in
some clones. The expression intensity
of nuclear GFP in cell types other than
cones varied among clones, with many
having no expression except in cones,
suggesting a positional effect of
nearby genomic elements on the cone
arrestin promoter.
The efﬁcacy of RNAi-mediated loss-
of-function in the pQCXIX vector was
tested by using an shRNA to a rod-
speciﬁc gene, phosphodiesterase beta
(Pde6b), whose loss-of-function muta-
tions in mice results in the death of
rods (Bowes et al., 1990). The shRNA
was driven from a U6 promoter that
was inserted upstream of the CMV
promoter pointing in the opposite di-
rection (see the Experimental Proce-
dures section). Infections of animals
heterozygous for Pde6b (rd1 mice) at
E9.5–E10.5 with pQCXIX encoding a
shRNA to Pde6b resulted in clones
with no rods (Fig. 4I–L). Because al-
most all control clones contain many
rods (Fig. 4M,N), the absence of rods
is presumably due to their death.
Gene transfer by electroporation.
Electroporation provides for the deliv-
ery of plasmids to cells at the injection
site. It has been successfully used for
delivery to postnatal ocular structures
in mice and rats, and embryonic eyes
of chicks (Schulte et al., 1999; Mat-
suda and Cepko, 2004). We explored
whether this method could be used to
transduce embryonic murine ocular
structures at different times. The
uterine wall is very thick at E9.5–
E10.5, preventing visualization of the
embryo after removal of the ultra-
sound scan-head, which is necessary
for proper placement of the electropo-
ration electrodes. Therefore, electro-
porations were not performed before
E12.5. After E12.5, the thickness of
the uterine wall was reduced, and the
embryo’s size was larger, allowing for
visualization and placement of the
electrodes. More importantly, survival
rates were very low after attempts to
electroporate at E9.5–10.5.
At or after E12.5, electroporation
into the eye was successful, and sev-
eral aspects of this method were thus
explored. Two differences between
electroporation and viral infection are
the number of targeted cells, the dis-
tribution of targeted cells, the stabil-
ity of expression, and the types of con-
structs that can be used for gene
transfer. Electroporation generally
targets many more cells in a local area
than viral infection, although this de-
pends in large part on the viral titer
and the skill of the investigator inject-
ing the DNA. In addition, electropo-
rated plasmids can be very large
whereas viral constructs are typically
more limited in size. Electroporation
of large DNA plasmids such as
phages, cosmids, or bacterial artiﬁcial
chromosomes (BACs) should be appli-
cable, as we have successfully used
BACs for electroporation in newborn
pups (Cherry and Cepko, unpublished
observations). Additionally, coelectro-
poration of several plasmids allows si-
multaneous introduction of several
genes into the same cells (Matsuda
and Cepko, 2004, 2007).
The identiﬁcation of retinae that
were successfully targeted was en-
abled by electroporation of a plasmid
encoding cytoplasmic GFP (Fig. 5A).
This showed the typical arrangement
of electroporated cells in which they
were clustered in a targeted domain.
Retinae that were electroporated at
E13 were easily identiﬁed at E17 (Fig.
5A), but by postnatal day 2, the over-
all signal after dissection was very
weak. By that time, the brightest sig-
nal was seen in the amacrine cells and
their processes in the developing in-
ner plexiform layer of the retina (Fig.
5C). This ﬁnding presumably was a
reﬂection of the fact that plasmids do
not integrate and are thus diluted at
each cell division. Cells that become
postmitotic shortly after electropora-
tion inherit the nonintegrated plas-
mid, but do not dilute it further with
additional cell divisions. Because am-
acrine cells are the most abundant of
the cell types born shortly after the
electroporation, they remain strongly
labeled (Fig. 5D) after embryonic elec-
troporation, as do some cone photore-
ceptors (Fig. 5E), which also have em-
bryonic birthdays (Carter-Dawson
and LaVail, 1979; Young, 1985).
DISCUSSION
Ultrasound-guided in utero injections
allow for studies of eye development
that were not feasible previously. This
includes spatiotemporal control of
both gain- and loss-of-function. The
choice of gene delivery method, by
means of virus or electroporation, de-
pends upon the application and
should be chosen according to the age
of delivery, number of cells to be tar-
geted, stability of expression, size of
construct(s), and whether or not mul-
tiple constructs need to be delivered.
Viral infections at E9.5–E10.5 usually
resulted in large clones composed of
multiple columns of densely packed
retinal cells, which should enable
studies of retinal physiology. Simi-
larly, studies of degeneration should
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1038 PUNZO AND CEPKObe possible, because by adjusting the
viral titer, clones covering up to 20%
of the retinal surface area can be
achieved. Animals infected with
pQCXIX could be easily identiﬁed by
GFP signal through the lens and thus
can be selected for follow-up studies,
for example, for physiology. In addi-
tion to gene transfer into the retina,
these methods also yielded gene
transfer of the RPE and sclera. Gene
transfer into other anterior chamber
structures such as the lens, the cor-
nea, and the ciliary margin should
also be possible, facilitating studies of
glaucoma, cataract, and corneal devel-
opment and diseases.
Gain-of-function by viral infection
can be performed by overexpression of
a gene in a broad or cell type-speciﬁc
manner by use of a cell type-speciﬁc
promoter that drives expression of the
gene of interest. Cell type-speciﬁc
overexpression can also be achieved
by infecting a Cre-expressing mouse
line with a virus where a ﬂox-stop cas-
sette precedes the gene of interest.
Similarly, a virus with a cell type-spe-
ciﬁc promoter that precedes a ﬂox-stop
cassette in front of the gene of interest
injected into a Cre-line with a differ-
ent promoter will result in overexpres-
sion at the intersection of two differ-
ent promoters. Gain-of-function by
electroporation is straight forward as
multiple plasmids can be electropo-
rated at the same time. In addition,
spatiotemporal control without the
use of Cre-lines has been reported suc-
cessfully for electroporations (Mat-
suda and Cepko, 2007). Analogous to
gain-of-function, loss-of-function can
be achieved by introducing a Cre or
Flp by means of viral infection or elec-
troporation into an animal engineered
to delete a locus of interest. An alter-
native approach is to deliver RNAi, by
means of a retroviral vector or electro-
poration.
Ultrasound-guided in utero injec-
tions during mouse eye development
provides a more rapid screening pro-
cess for novel gene function and pro-
moter activity than previously af-
forded by the use of genetically
modiﬁed mice. The ability to perform
experiments, including the generation
of loss-of-function clones similar to
those that have advanced the under-
standing of Drosophila eye develop-
ment, will enable scientists to dissect
the cellular interactions that govern
eye development in mouse. Screening
for disease models generated by
RNAi- or Cre-mediated loss-of-func-
tion, as well as rescue experiments in
retinal degeneration mutants, should
be straightforward. In addition, it is
likely that these methods can be
adapted to other species, thereby ex-
panding the production of disease
models to organisms where germline
engineering is impossible or impracti-
cal. While this work was in progress,
Garcia-Frigola et al., reported suc-
cessful electroporation in utero into
the embryonic mouse eye (Garcia-
Frigola et al., 2007). However, they
did not use ultrasound-guided injec-
tions and expression was conﬁned
mainly to amacrine and ganglion
cells. Due to the lack of ultrasound-
guided assistance, delivery of genes
earlier than E13 is also not feasible by
their method as the developing eye is
too small to be targeted.
EXPERIMENTAL
PROCEDURES
Animals
CD1, FVB/N, and C57Bl/6N were pur-
chased from Charles River Laborato-
ries, Inc. All procedures involving an-
imals were in compliance with the
ARVO Statement for the Use of Ani-
mals in Ophthalmic and Vision Re-
search.
Surgical Procedure and
Viral Injections
Survival rates and target efﬁciencies
are presented in Table 2. Survival
rates for pregnant animals of FVB/N
and C57Bl6 were 90% (18/20) and 87%
(7/8), respectively. Surgeries were per-
formed as previously described (Liu et
al., 1998) with some minor modiﬁca-
tions. Mice were anesthetized under
constant Isoﬂuorene ﬂow according to
the manufacturer’s directions. Injec-
tions were performed at all stages di-
rectly through the uterine wall either
into the diencephalon (E9.5–E10.5) or
into the subretinal space (E12.5)
while the needle was monitored by ul-
trasound. The imaging system used
(Vevo770) with a resolution of 30 m,
including surgical platform, microin-
jection apparatus, glass needles (Cus-
tom 0) with a 50-m beveled tip for
injections, scan-head holder, vapor-
izer, and accessories, were pur-
chased from Visual Sonics (http://
www.visualsonics.com). After the inci-
Fig. 2. Viral infections with LIA (A–C) and BAG (D–I) showing alkaline phosphatase and X-gal
staining, respectively, at postnatal day (P) 14. Injection age is indicated in the lower right of each
panel. A: Whole-mount view of a single LIA clone that was found to have an expected cellular
distribution of ONL and INL cells, as assessed by section analysis, after infection at embryonic day
(E) 9.5. Faint horizontal cells (arrows) are visible next to the main columns. B: Cross-section through
a retina of a LIA clone that did not contain the expected cellular distribution of ONL and INL cells
after infection at E9.5. Only photoreceptors in the ONL were seen. C: Whole-mount showing LIA
clones from E14.5 injections. Size of clones was smaller than those from E9.5 injections (compare
H with I). Clones were usually composed of one column (see also F and I). Viral titer was 5  10
5
CFU/ml (compare with F). D,E: Retinae after BAG infections at E9.5 from 3 surgeries performed in
one afternoon. Higher magniﬁcation of a retina from D (arrow) is shown in (E). F: Retina from an
E14.5 injection showing many small clones (an example of a single clone is indicated by the arrow).
Viral titer was 5  10
6 CFU/ml (compare with C). G: Flat mount of BAG infected retina at E9.5. Arrow
points to an example of a single clone that is composed of multiple columns. H: Cross-section
through a retina infected with BAG at E9.5. All labeled cells are part of a single clone. I: Cross-
section through retina in (F) showing three individual clones. ONL, outer nuclear layer; INL, inner
nuclear layer.
Fig. 3. Injections with the pQCXIX vector (pQC-H2BGFP-IX) at embryonic day (E) 9.5 (A–I). A–C:
Cross-section through retina at postnatal day (P) 28 showing nuclear green ﬂuorescent protein
(GFP) in all retinal layers. Red shows immunohistochemical signal from anti-red/green cone opsin
staining. Non-nuclear green signal shows cone segments labeled with PNA. (A) 4,6-diamidine-2-
phenylidole-dihydrochloride (DAPI); (B) nuclear, GFP encoded by the virus; (C) overlay. D: Fluo-
rescence visualized through the lens at P28. E: Side view of enucleated eye at P28 with cornea on
the left (arrow) and optic nerve to the right. In an albino background, ﬂuorescent retinal, retinal
pigmented epithelium (RPE), and scleral clones are seen together. F: Brightﬁeld and ﬂuorescence
image of an infected retina shown as a ﬂat mount, with photoreceptor surface up at 10 weeks of
age showing distribution of retinal clones. G,H: Flat mount at 10 weeks of age showing different
degrees of infection. Viral titer in G was 5  10
6 CFU/ml; in H, 10
7 CFU/ml (H shows ﬂuorescent
signal of F). I: Viral titer was 2  10
8 CFU/ml.
IN UTERO EYE TRANSDUCTION 1039sion of the skin and peritoneal muscle,
a sterile gauze with an incision was
placed over the opened body cavity
and wetted with sterile phosphate
buffered saline (PBS). At E9.5–E10.5,
one horn at a time was removed from
the body cavity and placed on sterile
gauze. At later stages (E12.5), three
to four embryos at a time were placed
onto the gauze. Embryos or horn were
covered directly with sterile ultrasound
gel, imaged, and injected with either 0.6
Fig. 4.
Fig. 5.
Fig. 4. Multiple applications of embryonic day
(E) 9.5 viral infections with pQCXIX. A–C: Post-
natal day (P) 28 retina. pQCXIX promotes coex-
pression due to an internal IRES, with a nuclear
green ﬂuorescent protein (GFP, A) 5 of the
IRES and a membrane-Cherry (B) 3 of the IRES
(pQC-H2BGFP-I-mCherry). C: Overlay of A and
B. D–H: Cell type-enriched expression in cones
after removal of the CMV promoter and re-
placement with the cone arrestin promoter
(pQmCAR-H2BGFP-IX). Red shows immuno-
histochemical signal for red/green opsin. D: An
infected retina (P28) prepared as a ﬂat mount
showing individual cones with nuclear GFP. E:
Low magniﬁcation of a cross-section at P28.
Non-nuclear green signal shows cone seg-
ments labeled with PNA. F,G: High magniﬁca-
tion of cross-section of retina at P13 showing
expression of nuclear GFP (F) in cells that also
express red/green cone opsin (G, arrows mark
cells that were GFP positive in F). H: Overlay of
F with 4,6-diamidine-2-phenylidole-dihydro-
chloride (DAPI). I–L: Absence of rods presum-
ably due to RNAi-mediated rod cell death in rd1
animals heterozygous for the rod-speciﬁc gene,
PDE6b. Animals were infected at E9.5 with a
virus carrying an shRNA for PDE6 (pQC-
H2BGFP-IX-RNAiPDE6b). Red shows immuno-
histochemical signal for red/green opsin. I,J:
Two different cross-sections at P35 showing
only inner nuclear layer cells and presumably
cones. K,L: Higher magniﬁcation of a single
confocal section from retina in J showing inner
nuclear layer cells and two cones (K) positive for
red/green opsin (L, arrows). M,N: Section of rd1
animals heterozygous for the rod-speciﬁc gene
PDE6b infected with a control virus expressing
only nuclear GFP (pQC-H2BGFP-IX). In addi-
tion to the inner nuclear layer cells, many rods
are positive for nuclear GFP. N: Same section
as in M without DAPI.
Fig. 5. Gene transfer by electroporation. A–E:
green ﬂuorescent protein (GFP) ﬂuorescence of
embryos electroporated at embryonic day (E)
13 with pCAG-GFP. A: Dissected eye cup at
E17.5 showing the electroporated area. B,C:
Cross-sections through electroporated retinae.
B: Section through retina shown in A at E17.5.
C: By postnatal day (P) 2, most of the signal
was found in amacrine cells (arrow) and devel-
oping amacrine processes in the inner plexi-
form layer, or in other early-born cell types,
such as cones (arrowhead). D,E: High magniﬁ-
cation at P2 showing an amacrine cell (D) and a
cone (E).
1040 PUNZO AND CEPKOl of virus at E9.5–E10.5 into the dien-
cephalon or 0.4 l of virus at E12.5
into the subretinal space. The needle
was preﬁlled with mineral oil and front
loaded before use, with sufﬁcient virus
to inject at least four embryos. After
injection, the gel was removed with a
squeeze bottle containing sterile PBS
and embryos were placed back into the
body cavity. The procedure was re-
peated with the second horn or with
additional embryos of the same horn if
only few embryos were removed instead
of the entire horn. At the end of the
injection procedure, the skin and peri-
toneal muscle were sutured individu-
ally. A single injection of 0.05 mg/kg
body weight of buprenorphine was ad-
ministered after the surgery and re-
peated for an additional 3 times in
12-hr intervals.
Electroporation
For electroporations (E12.5), the gel
was washed off (PBS squeeze bottle)
from the embryo to be electroporated.
The positive pole of the electrode was
placed over the side of the eye and the
negative on the other side of the head.
Five pulses of 50 msec with 950-msec
intervals were applied. Voltage was
adjusted to the age of the embryo and
may be further adjusted to different
strains. Ideally, electroporation tests
without injections allow determina-
tion of the best conditions for a partic-
ular strain and electroporation setting
by assessing survival ﬁrst. Recom-
mended voltages are as follow: E12.5,
20–25 V; E13.5–E14.5, 25–30 V;
E15.5 on, 35–40 V. DNA concentra-
tion ranged between 1 and 1.5 g/l
with a volume of 0.4 l injected into
the subretinal space. The needle was
usually front loaded as for viral injec-
tions but can also be back loaded if
desired. After injection, the embryo
was immediately electroporated be-
fore moving to the next one. The plas-
mid used for electroporation expresses
a cytoplasmic GFP under the control
of the CAG promoter (Matsuda and
Cepko, 2004). Electroporation device
ECM830 and tweezer-type electrodes
(model 520, 7 mm diameter) were pur-
chased from BTX, San Diego.
Virus Work and Constructs
Viral preparations and concentration
through centrifugation were performed
as described previously (Cepko, 1989).
Titers obtained with FUGW ranged be-
tween 5  10
6 and 2  10
7 CFU/ml.
Titers obtained with LIA ranged from
5  10
5 to 10
7 CFU/ml. Titers obtained
with BAG ranged between 10
6 and 2 
10
7 CFU/ml. LIA and BAG require a
histochemical reaction (Turner et al.,
1990; Fields-Berry et al., 1992); there-
fore, all eyes of the litter have to be
processed to determine the infected
ones. Additionally, the strong staining
of the alkaline phosphatase and -gala-
cotsidase reaction throughout the mem-
brane and cytoplasm, respectively, can
complicate interpretations of densely
packed clonally related cells. Unless
used in combination with antibodies,
they are not suitable for ﬂuorescent mi-
croscopy and double or triple labeling.
The vector, pQCXIX has no marker
gene but allows for insertion of two
genes (at the position X). It, like LIA,
has an IRES (here abbreviated I) ele-
ment allowing for expression of two
genes from a bicistronic mRNA.
pQCXIX was purchased from Clontech
(catalog no. 631515). A test vector was
generated with a histone GFP fusion
(H2BGFP) inserted into the ﬁrst multi-
ple cloning site (MCS) and a new ex-
tended second MCS. Titers with
pQCXIX ranged from 5  10
6 to 2  10
8
CFU/ml. Viruses made from the con-
struct that replaced the CMV promoter
with the cone arrestin promoter (Zhu et
al., 2002) cannot be titered by determin-
ing the amount of infectious particles,
due to lack of expression in cell culture.
To estimate the viral titer, the virus
with the CMV promoter and the one
with the cone arrestin promoter were
made in parallel and the relative
amount of viral genome was assessed
by quantitative real-time polymerase
chain reaction (PCR), which was then
compared with the titer of infectious
particles for the virus with the CMV
promoter. The H2BGFP fusion con-
struct was performed by PCR. NotI was
added at the 5 end and MnuIa tt h e3 
end and the fusion was cloned into the
ﬁrst MCS of pQCXIX into NotI and
EcoRI to generate pQC-H2BGFP-IX.
TABLE 2. Summary of Plasmids Used for Gene Transfer Either by Viral Infection or Electroporation
a
Virus Promoter Reporter; localization Injected at Figure
LIA LTR Alkaline phosphatase; membrane E9.5
E14.5
2A, 2B
2C
BAG LTR -galactosidase; cytoplasm E9.5
E14.5
2D, 2E, 2G, 2H
2F, 2I
FUGW Ubiquitin C GFP; cytoplasm E9.5
E13.5
not shown
pQC-H2BGFP-IX CMV GFP; nuclear E9.5 3B-3I
4M, 4N
pQC-H2BGFP-I-mCherry CMV GFP; nuclear
Cherry; membrane
E9.5 4A-4C
pQmCAR-H2BGFP-IX Cone arrestin GFP; nuclear E9.5 4D-4H
pQC-H2BGFP-IX-RNAiPDE6b CMV GFP; nuclear E9.5 4I-4L
Electroporation plasmid
pCAG-GFP CAG GFP; cytoplasm E13 5A-5E
aPromoter, marker gene, time point of injection, and corresponding ﬁgures are indicated. GFP, green ﬂuorescent protein; E,
embryonic day.
IN UTERO EYE TRANSDUCTION 1041The following restriction sites were
added into the second MCS between
MluI and XhoI: BsiwI, SgrAI, AccIII,
MnuI, PacI (Supplementary Map/Se-
quence, which can be viewed at http://
www.interscience.wiley.com/jpages/
1058-8388/suppmat). The cone arres-
tin promoter (Zhu et al., 2002) was
obtained by PCR from genomic DNA.
An XbaI site and a NotI site were
added at the 5 end and at the 3 end,
respectively, and cloned into XbaI and
NotI of pQC-H2BGFP-IX by replacing
the CMV promoter to generate the
pQmCAR-H2BGFP-IX (Supplemen-
tary Map/Sequence). The following
targeting sequence was used for the
PDE6b shRNA construct: 5-GGGCCT-
GTGAAGATGGTTGGCA-3and cloned
into pBS/U6 (kindly provided by Dr.
Yang Shi, Harvard Medical School, Bos-
ton, MA). The U6 promoter and the
shRNA construct was excised as an
XbaI cassette and cloned into XbaIo f
pQC-H2BGFP-IX. Orientation was ver-
iﬁed to select for clones where the U6
promoter pointed in the opposite di-
rection as the CMV promoter (Supple-
mentary Map/Sequence). MluI and
XhoI were added at the 5 and at the
3 end of membrane-Cherry (mCherry
was kindly provided by Dr. Botond
Roska, FMI, Basel Switzerland) by
PCR. mCherry was cloned as MluI–
XhoI fragment into MluI–XhoIo f
pQC-H2BGFP-IX to generate pQC-
H2BGFP-I-mCherry (Supplementary
Map/Sequence).
Immunohistochemistry
Whole-mount.
Retinae were dissected in PBS, ﬁxed
for 30 min in 4% paraformaldehyde/
PBS, washed 3  10 min in PBS,
washed for 1 hr in PBT (PBS, 0.3%
Triton 100), blocked for 1 hr in PBTB
(PBT, 5% BSA), incubated overnight
at 4°C with primary antibody in
PBTB, washed 3  20 min with PBTB,
incubated 2 hr with secondary anti-
body in PBTB, washed 5  20 min in
PBT. Sections, dissection, ﬁxation,
and washes were performed as for
whole-mount retinae, then retinae
were equilibrated in increasing su-
crose concentrations (from 5% to 30%
sucrose/PBS), mounted in OCT, fro-
zen, sectioned, re-hydrated in PBS for
30 min, and then the same procedure
was used again as for whole-mount
starting with the 1 hr wash step in
PBT. Primary antibody dilutions: rab-
bit -red/green opsin (Chemicon),
1:300; Lectin PNA conjugate Alexa-
488, 1:400 (Molecular Probes); rabbit
-GFP, 1:1,000 (Molecular Probes).
Secondary antibody dilutions were
F(ab)2 fragments (Jackson Immu-
noResearch) 1:500 on sections or
whole-mount.
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